AVGEMSI
Gemcitabine
- Strength
- 38 mg/mL
- Form
- Injection, Solution
- Class
- Nucleoside Metabolic Inhibitor
Avyxa Pharma, LLC
Not stocked by us — reference only
gemcitabine intravesical
Listed by Janssen Biotech, Inc
| Dosage form | System |
|---|---|
| Route | Intravesical |
| Drug class | Nucleoside Metabolic Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 57894-225 |
| FDA application | NDA219683 |
| RxNorm concept | 2723386 |
| Package sizes listed | 2 |
| Marketed since | September 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Gemcitabine
Avyxa Pharma, LLC
Not stocked by us — reference only
Gemcitabine
Avyxa Pharma, LLC
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
GEMCITABINE HYDROCHLORIDE
Mylan Institutional LLC
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
Hospira, Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.